KleinRKleinBEKMossSEDavisMDDemetsDL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathyJAMA1988, 260:2864–2871.
2.
SteffesMWSutherlandDERGoetzFCRichSSMauerSM: Studies of kidney and muscle biopsy specimens from identical twins discordant for type 1 diabetes mellitusN Engl J Med1985, 312:1282–1287.
3.
EngermanRLKernTS: Progression of incipient diabetic retinopathy during good glycemic controlDiabetes1987, 36:808–812. ∗ Documents the progression of diabetic retinopathy in an animal model even after glycemic control is reestablished.
4.
ReichardPNilssonBYRosenqvistU: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitusN Engl J Med1993, 329:304–309. * Documents the benefits of intensive insulin treatment and good glycemic control on the prevention of chronic microangiopathic complications. Also shows in human a time lag of 90 months before the benefit of reduced serious retinopathy becomes apparent in the intensive treatment group.
5.
TookeJE: Microvascular function in human diabetesDiabetes1995, 44:721–726. * Evidence to support the role of altered hemodynamics in the pathogenesis of microangiopathy.
6.
TookeJE: Microvascular hemodynamics in diabetes mellitusClin Sci1986, 70:119–125.
7.
WilliamsSAWassermannSRawlinsonDWKitneyRISmajeLHTookeJE: Dynamic measurement of human capillary blood pressureClin Sci1988, 74:507–512.
8.
SandemanDDShoreACTookeJE: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic controlN Engl J Med1992, 327:760–764.
9.
ShoreACPriceKJSandemanDDTrippJHTookeJE: Posturally induced vasoconstriction in diabetes mellitusArch Dis Childhood1994, 70:22–26.
10.
ShoreACJaapAJTookeJE: Capillary pressure in insulin dependent diabetic patients of long disease duration with and without microangiopathyDiabetic Med1992, 9 (Suppl. 2):S11.
11.
WilliamsSABoolellMMacGregorGASmajeLHWassermanSMTookeJE: Capillary hypertension and abnormal pressure dynamics in patients with essential hypertensionClin Sci1990, 79:5–8.
12.
BerkmanJRifkinH: Unilateral nodular diabetic glomerulosclerosis (Kimmel-Steel-Wilson): Report of a caseMetabolism1973, 22:715–722.
13.
DukerJSBrownGCBosleyTMColtCAReberR: Asymmetric proliferative diabetic retinopathy and carotid artery diseaseOphthalmology1990, 97:869–874.
14.
TesfamariamBBrownMLDeykinDCohenRA: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aortaJ Clin Invest1990, 85:929–932.
15.
TakahashiKGhateiMALamHCO'HalloranDJBloomSR: Elevated plasma endothelin in patients with diabetes mellitusDiabetologia1990, 33:306–310.
16.
MolinattiPAPortaMTakahashiKKanseSMBrooksRABloomSRKohnerEM: Endothelin-1 production is reduced in retinal capillary endothelial cells cultured in high glucose [abstract]Diabetologia1990, 33:A51.
17.
NjorogeFGMonnierVM: The chemistry of the Maillard reaction under physiological conditions: A reviewProg Clin Biol Res1989, 304:85–107.
18.
BrownleeMCeramiAVlassaraH: Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complicationsN Engl J Med1988, 318:1315–1321.
19.
LedlFSchleicherE: New aspects of the Maillard reaction in foods and in the human body. 1990, 6:565–706.
20.
PerejdaAJUittoJ: Nonenzymatic glycosylation of collagen and other proteins: Relationship to development of diabetic complicationsCollagen Relat Res1982, 2:81–88.
21.
ChangKUlittoJRowoldEAGrantGAKiloCWilliamsonJR: Increased collagen cross-linkages in experimental diabetes: Reversal by B-amino-propionitrile and D-penicillamineDiabetes1980, 29:778–781.
22.
MonnierVMVishwanathVFrankKEElmetsCADauchotPKohnRR: Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescenceN Engl J Med1986, 314:403–408.
23.
BucalaRTraceyKJCeramiA: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetesJ Clin Invest1991, 87:432–438.
24.
HoganMCeramiABucalaR: Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide: Role in the vascular and renal complications of diabetes mellitusJ Clin Invest1992, 90:1110–1115.
25.
Soulis-LiparotaTCooperMPapazoglouDClarkeBJerumsG: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic ratDiabetes1991, 40:1328–1334.
26.
KiharaMSchmeltzerJDPodusloJFCurranGLNickanderKKLowPA: Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicalsProc Natl Acad Sci USA1991, 88:6107–6111.
27.
SuarezGRajaraniRBhurjanKCOronskyLGoidiJA: Administration of aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic ratsJ Clin Invest1988, 82:624–627.
28.
NichollsKMandelTE: Advanced glycosylation end products in experimental murine diabetic nephropathy: Effect of islet grafting and aminoguanidineLab Invest1989, 60:486–491.
29.
OsterbyR: Basement membrane morphology in diabetes mellitus. In Diabetes Mellitus. Edited by RifkinHPortDJ.New York: Elsevier, 1990.
30.
WilliamsonJRKiloC: Current status of capillary basement-membrane disease in diabetes mellitusDiabetes1977, 26:65–73.
31.
VrackoR: Skeletal muscle capillaries in diabeticsCirculation1970, 41:271–283.
32.
LiWShenSKhatamiMRockeyJH: Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high-glucose concentrationDiabetes1984, 33:785–789.
33.
CaglieroEMaielloMBoeriDRoySLorenziM: Increased expression of basement membrane components in human endothelial cells cultured in high glucoseJ Clin Invest1988, 82:735–738.
34.
BermanALedbetterS: Regulation of type IV collagen mRNA in retinal capillary endothelial cells and pericytes by glucose levels and aldose reductase inhibitor, sorbinil [abstract]Diabetes1988, 37 (suppl 1):96A.
ReddiAS: Collagen metabolism in the retina of normal and diabetic ratsExp Eye Res1985, 41:345–352.
37.
Panush CohenMKhalifaA: Renal glomerular collagen synthesis in streptozotocin diabetes: Reversal of increased basement membrane synthesis with Insulin therapyBiochim Biophys Acta1977, 500:395–404.
38.
SprioRGSpiroMJ: Effect of diabetes on the biosynthesis of the renal glomerular basement membrane: Studies on the glucosyltransferaseDiabetes1971, 20:641–648.
39.
SteffesMWOsterbyRChaversBMauerSM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patientsDiabetes1989, 38:1077–1081.
40.
RiserBLCortesPZhaoXBernsteinJDumlerFNarinsRG et al.: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the ratJ Clin Invest1993, 91:1932–1943.
41.
CoganDGToussaintDKuwabaraT: Retinal vascular patterns. IV. Diabetic retinopathyArch Ophthalmol1961, 66:366–378.
42.
AshtonN: Studies of the retinal capillaries in relation to diabetic and other retinopathiesBr J Ophthalmol1963, 47:521–538.
43.
TiltonRGFallerANBurkhardtJKHoffmannPLKiloCWilliamsonJR: Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patientsDiabetologia1985, 28:898–900.
44.
VrackoR: A comparison of the microvascular lesions in diabetes mellitus with those in normal agingJ Am Geriatr Soc1982, 30:201–205.
45.
FentonBMZweifachBWWorthenDM: Quantitative morphometry of conjunctival microcirculation in diabetes mellitusMicrovasc Res1979, 18:153–166.
46.
JakobsenJSideniusPGundersenHJGOsterbyR: Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in ratsDiabetes1987, 36:597–601.
47.
LorenziMCaglieroE: Pathobiology of endothelial and other vascular cells in diabetes mellitusDiabetes1991, 40:653–659. ∗ Documents changes in microvascular cells with diabetes and critiques areas which need further investigation.
48.
SpeiserPGittelsohnAMPatzA: Studies on diabetic retinopathy. III. Influence of diabetes on intramural pericytesArch Ophthalmol1968, 80:332–337.
49.
BitoALDeRousseauCJ: Transport function of the blood-retinal barrier system and the micro-environment of the retina. In The Blood Retinal Barriers. Edited by Chauna-VazJD.New York: Plenum Press, 1980.
50.
BloodworthJMB: A re-evaluation of diabetic glomerulo-sclerosis 50 years after the discovery of insulinHuman Pathol1978, 9:439–453.
51.
FactorSMOkunEMMinaseT: Capillary microaneurysms in the human diabetic heartN Engl J Med1980, 302:384–388.
KadorPFAkagiYTakahashiYIkebeHWymanMKinoshitaJH: Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitorsArch Ophthalmol1990, 108:1301–1309.
54.
SatoYRifkinDB: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transformation growth factor B1-like molecule by plasmin during co-cultureJ Cell Biol1989, 109:309–315.
55.
Antonelli-OrlidgeASaundersKBSmithSRD'AmorePA: An activated form of transforming growth factor B is produced by cocultures of endothelial cells and pericytesProc Natl Acad Sci USA1989, 86:4544–4548.
WilliamsonJRChangKFrangosMHasanKSIdoYKawamuraT et al.: Perspectives in diabetes: Hyperglycemic pseudohypoxia and diabetic complicationsDiabetes1993, 42:801–813.
58.
United Kingdom Prospective Diabetes Study: United Kingdom Prospective Diabetes Study III: Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetesHypertension1985, 7 (suppl 2):8–13.
59.
SandemanDDPymCAGreenEMSeamarkCShoreACTookeJE: Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patientsBMJ1991, 302:1122–1123.
60.
JaapAJHammersleyMSShoreACTookeJE: Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitusDiabetologia1994, 37:214–216.
61.
WelbornTABreckenridgeARubinsteinAHDolleryCTFraserTR: Serum insulin in essential hypertension and in peripheral vascular diseaseLancet1966, i:1336–1337.
62.
DonahueRPSkylerJSSchneiderianNPrineasRJ: Hyperinsulinemia and elevated blood pressure: Cause, confounder, or coincidence?Am J Epidemiol1990, 132:827–836.
63.
KaplanNM: The deadly quartet: Upper-body adiposity, glucose intolerance, hypertriglyceridemia and hypertensionArch Intern Med1989, 149:1514–1520.
64.
HaffnerSMValdezRAHazudaHPMitchellBDMoralesPA: Prospective analysis of the insulin resistance syndrome (syndrome X)Diabetes1992, 41:715–722.
65.
SternMPMoralesPAHaffnerSMValdezRA: Hyperdynamic circulation and the insulin resistance syndrome (‘syndrome X’)Hypertension1992, 20:802–808.
66.
JiangXSrinivasanSRUrbinaEBerensonGS: Hyperdynamic circulation and cardiovascular risk in children and adolescents. The Bogalusa Heart StudyCirculation1995, 91:1101–1106.
67.
Juhan-VagueIAlessiMCVagueP: Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and artherothrombosisDiabetologia1991, 34:457–462.
68.
SchneiderDJNordtTKSobelBE: Attenuated fibrinolysis and accelerated atherosclerosis in type II diabetic patientsDiabetes1993, 42:1–7.
69.
KooistraTBosmaPJTonsHAMvan den BergAPMeyerPPrincenHMG: Plasminogen activator inhibitor 1: Biosynthesis and mRNA level are increased by insulin in cultured human hepatocytesThromb Haemos1989, 62:723–728.
70.
NordtTKSawaHFujiiSSobelBE: Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulinin vivo. Circulation1995, 91:764–770.
71.
KollrosPRKonkleBAAmbarianAPHenriksonP: Plasminogen activator inhibitor-1 expression by brain microvessel endothelial cells is inhibited by elevated glucoseJ Neurochem1994, 63:903–909.
72.
WerbZBandaMJJonesPA: Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophagesJ Exp Med1980, 152:1340–1357.
73.
WerbZMainardiCVaterCAHarrisJED: Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activatorN Engl J Med1977, 296:1017–1023.
74.
IngberDEFolkmanJ: How does extracellular matrix control capillary morphogenesis?Cell1989, 58:803–805. ∗ This reference presents an interesting perspective on matrix cell interactions.
75.
HsuehWAAndersonPW: Systemic hypertension and the renin-angiotensin system in diabetic vascular complicationsAm J Cardiol1993, 72:14H–21H.
76.
KarpenCWSpanheimerRGRandolphALLoweJWL: Tissue-specific regulation of basic fibroblase growth factor mRNA levels by diabetesDiabetes1992, 41:222–226.
77.
RudermanNBWilliamsonJRBrownleeM: Glucose and diabetic vascular diseaseFASEB J1992, 6:2905–2914. ∗ This review examines how diabetes causes disruptions in cell physiology. It describes a number of pathophysiologic sequences and how they may relate to one another.
GreeneDALattimerSASimaAAF: Pathogenesis and prevention of diabetic neuropathyDiab/Metab Rev1988, 5:202–221.
80.
WinegradAI: Does a common mechanism induce the diverse complications of diabetes?Diabetes1987, 36:396–406.
81.
CravenPADavidsonCMDeRubertisFR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipidsDiabetes1990, 39:667–674.
82.
LeeTSMacGregorLCFluhartySJKingGL: Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cellsJ Clin Invest1989, 83:90–94.
83.
LeeTSSaltsmanKAOhashiHKingGL: Activation of protein kinase C by elevated glucose concentration: Proposal for a mechanism in the development of diabetic vascular complicationsProc Natl Acad Sci USA1989, 86:5141–5145.
84.
CravenPADePubertisFR: Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic ratMetabolism1989, 38:649–654.
85.
SimmonsDAWinegradAI: Mechanism of glucose-induced (Na,K)-ATPase inhibition in aortic wall of rabbitsDiabetologia1990, 32:402–408.
86.
PuglieseGTiltonRGSpeedyASantarelliEEadesDMProvinceMA et al.: Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositolDiabetes1990, 39:312–322.